| Bioactivity | BCAT-IN-4 (Compound 1) is a BCAT inhibitor. BCAT-IN-4 exhibits a moderate ability to inhibit hBCATc with IC50 value of 2.35 μM. BCAT-IN-4 can be used for the research of neurodegenerative diseases[1]. |
| Target | IC50: 2.35 μM (hBCATc). |
| Name | BCAT-IN-4 |
| CAS | 406190-85-0 |
| Formula | C19H14N2O4S |
| Molar Mass | 366.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Hu LY, et al. The design and synthesis of human branched-chain amino acid aminotransferase inhibitors for treatment of neurodegenerative diseases. Bioorg Med Chem Lett. 2006 May 1;16(9):2337-40. |
BCAT-IN-4
CAS: 406190-85-0 F: C19H14N2O4S W: 366.39
BCAT-IN-4 (Compound 1) is a BCAT inhibitor. BCAT-IN-4 exhibits a moderate ability to inhibit hBCATc with IC50 value of 2
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.